Benjamin Safirstein, MD


Dr. Benjamin Safirstein joined ArmadaGlobal as its Chief Medical Officer in 2008. He brings deep experience in the healthcare field as a practicing physician, managed care medical director and visionary leader in the health advisory services sector. He has extensive peer relationships with leading physician specialists around the globe and has dedicated much of his career in evaluating clinical outcomes and “best care” providers.

Dr. Safirstein is currently Clinical Associate Professor of Medicine at the Mount Sinai Medical School. He is the founder and past president of the Asthma Institute of New Jersey and Chairman of the Scientific Committee of the Arthur Ashe Institute for Urban Medicine.

Dr. Safirstein completed his training in Internal Medicine at the Mount Sinai Medical Center and his fellowship in Pulmonary Medicine at the Institute for Disease of the Chest in London, England. He has authored more than 50 peer-reviewed articles on a wide range of pulmonary topics including asthma, occupational lung disease, sarcoidosis, and lung cancer. He is Board Certified in Internal Medicine and Pulmonary Medicine and a Fellow of the American College of Physicians and the American College of Chest Physicians. He is also a member of AOA Honor Medical Fraternity and the recipient of the Distinguished Alumni Award of the Chicago Medical School.

Dr. Safirstein was previously Chief Medical Officer and served as corporate Executive Vice President of Flagship Global Health, a membership-based, private medical group focused on attaining better healthcare services for its members. Acting as a member’s healthcare advocate, FGH provided facilitated access to clinically acclaimed physicians and health care knowledge.

Prior to Flagship Global Health, Dr. Safirstein co-founded and served as Medical Director and Vice President of Oxford Health Plans, a prominent, ground-breaking managed care organization in the Northeastern United States that included a network of high-quality doctors and leading hospitals. Dr. Safirstein was the accredited executive manager of the clinically based programs. In this capacity, he helped Oxford grow to a company generating nearly $2B annually in revenues.